Healthcare
Live Price
Offline$20.00
+0.15% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cardiovascular Systems, Inc. (CSII) is a Healthcare stock with a market cap of $843.96M. The stock last traded around $20.00. Baseline metrics include revenue growth of -8.8%, EPS growth of -168.6%, a dividend yield of 0.0%. What stands out right now is revenue -8.8%, EPS -168.6%, free cash flow -488.9% with operating margin -15.2% and ROIC -12.7%. Valuation is more restrained than many high-expectation growth names at price/sales 3.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CSII price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CSII
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CSII Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CSII and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$217.0M
-12.5% YoY
FY Net Income
$1.7M
+771.4% YoY
Free Cash Flow
$6.6M
-0.7% YoY
Revenue Growth
-8.8%
EPS Growth
-168.6%
Gross Margin
73.1%
Net Margin
-15.6%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 236M | 259M | 237M | 248M | 217M |
| Gross Profit | 173M | 198M | 188M | 200M | 178M |
| Operating Income | -36M | -12M | -27M | -825K | -2M |
| EBITDA | -34M | -10M | -24M | 5M | 2M |
| Net Income | -37M | -13M | -27M | -255K | 2M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 66M | 71M | 185M | 74M | 116M |
| Total Assets | 323M | 353M | 340M | 219M | 203M |
| Total Liabilities | 73M | 82M | 71M | 71M | 69M |
| Shareholder Equity | 249M | 271M | 269M | 148M | 134M |
| Total Debt | 20M | 21M | 21M | 21M | 21M |
| Net Debt | -46M | -50M | -165M | -53M | -95M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
10M
-5.2% YoY
Capital Expenditures
3M
+13.7% YoY
Free Cash Flow
7M
-0.7% YoY
Key ratios
Gross Margin
73.1%
Operating Margin
-15.2%
Net Margin
-15.6%
ROE
-14.2%
Debt / Equity
0.08x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.